Chronic low-grade inflammation is a key driver of metabolic dysfunction in obesity, and targeting MMP-9 may help reduce tissue remodeling and systemic inflammation. This evidence concerns the gene MMP9 and obesity due to melanocortin 4 receptor deficiency.